关注
Dirk Dressler
Dirk Dressler
未知所在单位机构
在 mh-hannover.de 的电子邮件经过验证
标题
引用次数
引用次数
年份
Electric and magnetic stimulation of human motor cortex: surface EMG and single motor unit responses.
BL Day, D Dressler, A Maertens de Noordhout, CD Marsden, ...
The Journal of physiology 412 (1), 449-473, 1989
11681989
Botulinum toxin: mechanisms of action
D Dressler, F Adib Saberi
European neurology 53 (1), 3-9, 2005
7062005
Brain parenchyma sonography discriminates Parkinson’s disease and atypical parkinsonian syndromes
U Walter, L Niehaus, T Probst, R Benecke, BU Meyer, D Dressler
Neurology 60 (1), 74-77, 2003
3322003
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...
The Lancet Neurology 16 (9), 701-711, 2017
2972017
Facing depression with botulinum toxin: a randomized controlled trial
MA Wollmer, C de Boer, N Kalak, J Beck, T Götz, T Schmidt, M Hodzic, ...
Journal of psychiatric research 46 (5), 574-581, 2012
2952012
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders
M Hallett, A Albanese, D Dressler, KR Segal, DM Simpson, D Truong, ...
Toxicon 67, 94-114, 2013
2742013
Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease
U Walter, M Wittstock, R Benecke, D Dressler
Journal of neural transmission 109, 191-196, 2002
2522002
Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease
U Walter, D Dressler, T Probst, A Wolters, M Abu-Mugheisib, M Wittstock, ...
Archives of neurology 64 (11), 1635-1640, 2007
2342007
Pharmacology of botulinum toxin: differences between type A preparations
RL Rosales, H Bigalke, D Dressler
European Journal of Neurology 13, 2-10, 2006
2212006
Clinical applications of botulinum toxin
D Dressler
Current opinion in microbiology 15 (3), 325-336, 2012
2102012
Immunological aspects of Botox®, Dysport® and MyoblocTM/NeuroBloc®
D Dressler, M Hallett
European Journal of Neurology 13, 11-15, 2006
2032006
Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis
D Dressler, R Benecke
European neurology 49 (1), 34-38, 2002
2032002
Pharmacology of therapeutic botulinum toxin preparations
D Dressler, R Benecke
Disability and rehabilitation 29 (23), 1761-1768, 2007
1992007
Brain parenchyma sonography detects preclinical parkinsonism
U Walter, C Klein, R Hilker, R Benecke, PP Pramstaller, D Dressler
Movement disorders 19 (12), 1445-1449, 2004
1982004
Clinical presentation and management of antibody‐induced failure of botulinum toxin therapy
D Dressler
Movement Disorders: Official Journal of the Movement Disorder Society 19 (S8 …, 2004
1892004
Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence
MB Lukban, RL Rosales, D Dressler
Journal of Neural Transmission 116, 319-331, 2009
1712009
Neuroimaging in stroke recovery: a position paper from the First International Workshop on Neuroimaging and Stroke Recovery
H Christensen, L Derex, JB Pialat, M Wiart, N Nighoghossian, M Hermier, ...
Cerebrovascular diseases 18 (3), 260-267, 2004
1692004
Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy
U Walter, D Dressler, A Wolters, T Probst, A Grossmann, R Benecke
Neurology 63 (3), 504-509, 2004
1642004
GPi-DBS may induce a hypokinetic gait disorder with freezing of gait in patients with dystonia
C Schrader, HH Capelle, TM Kinfe, C Blahak, H Bäzner, G Lütjens, ...
Neurology 77 (5), 483-488, 2011
1612011
The syndrome of painful legs and moving toes
D Dressler, PD Thompson, RF Gledhill, CD Marsden
Movement Disorders 9 (1), 13-21, 1994
1571994
系统目前无法执行此操作,请稍后再试。
文章 1–20